Challenges in decolonizing linguistics: the politics of enregisterment and the divergent uptakes of translingualism
Educational Linguistics · 27.06.2022 · 1 (1) · 25-55
DOI: 10.1515/eduling-2021-0005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Educational Linguistics, online erschienen am 01.02.2022. Verfasst von Suresh Canagarajah. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
This article traces the roots of translingualism in the Global South, with particular relevance to the author’s South Asian heritage. After narrating his attempts to practice this orientation in his research and scholarship, the author analyzes the problematic ways in which translingualism is appropriated in the academic, economic, and political contexts in Global North. Employing the conceptual orientation of enregisterment, the article theorizes the challenges for decolonizing discourses in negotiating a critical and transformative uptake. It concludes by outlining some strategies that can help in entextualizing translingualism to preserve its decolonizing potential. It identifies areas of research that will expand the communities, contexts, and communication that will facilitate more pluriversal epistemologies and practices.
Zitieren
APA
Canagarajah, S. (2022). Challenges in decolonizing linguistics: the politics of enregisterment and the divergent uptakes of translingualism. Educational Linguistics, 1(1), 25-55. https://doi.org/10.1515/eduling-2021-0005
Vancouver
Canagarajah S. Challenges in decolonizing linguistics: the politics of enregisterment and the divergent uptakes of translingualism. Educational Linguistics. 2022;1(1):25-55. doi:10.1515/eduling-2021-0005
BibTeX
@article{Canagarajah2022,
author = {Canagarajah, Suresh},
title = {Challenges in decolonizing linguistics: the politics of enregisterment and the divergent uptakes of translingualism},
journal = {Educational Linguistics},
year = {2022},
volume = {1},
number = {1},
pages = {25--55},
doi = {10.1515/eduling-2021-0005}
}
EUVIMED